Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
2012Final results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)Готько, Євген Степанович; Alberto F. Sobrero; Marc Peeters; Timothy Jay Price; Andres Cervantes-Ruiperez; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Ying Tian; Roger Sidhu
2015Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal CancerГотько, Євген Степанович; Marc Peeters; Kelly S. Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Cornelis J. A. Punt; Andrew Strickland
2012Final results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)Alberto F. Sobrero; Marc Peeters; Timothy Jay Price; Yevhen Hotko; Andres Cervantes-Ruiperez; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Ying Tian; Roger Sidhu
2015Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal CancerMarc Peeters; Kelly S. Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Yevhen Hotko; Thierry Andre; Emily Chan; Florian Lordick; Cornelis J. A. Punt; Andrew Strickland; Gregory Wilson; Tudor-Eliade Ciuleanu; Laslo Roman; Eric Van Cutsem; Ying Tian; Andre Scott Jung; Roger Sidhu; Scott D. Patterson
2014-05-20Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).Готько, Євген Степанович; Marc Peeters; Kelly Smith Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Cornelis JA Punt; Andrew Strickland; Gregory Wilson
2014-05-20Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).Marc Peeters; Kelly Smith Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Yevhen Hotko; Thierry Andre; Emily Chan; Florian Lordick; Cornelis JA Punt; Andrew Strickland; Gregory Wilson; Tudor E Ciuleanu